Surgical Pathology of Wide Local Excision of Breast

Slides:



Advertisements
Similar presentations
Updates on Breast Diseases: What clinicians need to know from pathologists Preah Bat Norodom Sihanouk Hopsital, 22 April 2009 Monirath Hav, MD, Ph.D. fellow.
Advertisements

Pimp Session: Breast By James Lee, MD.
Polyps – Where do they come from and what do you do with them?!
Tumor Size and Sentinel Node Procedure A. Ph. MAKAR, MD, Ph.D. R. Van Den Broecke, MD, Ph.D. Depart of Senology & Gynaecologic Oncology The Middelheim.
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
SQUAMOUS CELL CARCINOMA
Specimen collection pgs , , and The lab or pathology department does countless types of examinations on every type of body.
Skin Lesion James Warneke, MD University of Arizona.
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
Sentinel Lymph Node Biopsy in Melanoma
Histopathology and staging of breast cancer
Using the EHR for the identification of patients at high risk for hereditary breast and ovarian cancer. Brian Drohan University of Massachusetts 5/30/08.
Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.
Procedures used by CHTN
AJCC TNM Staging 7th Edition Breast Case #3
Faculty of Medicine - Benha University
Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients Dr S.Gambhir Department of Nuclear Medicine S.G.P.G.I.M.SLucknow.
Radiotherapy in Carcinoma of the Breast Patrick S Swift, MD Director, Radiation Oncology Alta Bates Comprehensive Cancer Center Berkeley, CA.
Ductal Carcinoma in situ
BREAST CANCER PROF.NAZEM SHAMS. IS IT A SERIOUS PROBLEM ??
Chapter 4 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Melanoma Hai Ho, M.D. Department of Family Practice.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
IMPROVED BREAST CANCER DIAGNOSIS AND PROGNOSIS BY
Sentinel Node Biopsy : the way forward Hemant Singhal MS FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Northwick Park & St Marks Hospital Senior Lecturer,
Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital
BCT: Towards Optimal Outcomes
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
Cytology and Cytological Techniques
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Management of DCIS KWH Experience Dr. Carmen Ho.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.
Ductal Carcinoma In Situ Shahla Masood, M.D. Professor of Pathology University of Florida College of Medicine - Jacksonville Chief of Pathology and Laboratory.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Pathology Reports Nicole Draper, MD.
Margin evaluation in Breast Conservation Treatment Dr. C. Gopalakrishnan Nair Department of endocrine Surgery College of Medicine AIMS Kochi, Kerala These.
Tissue Processing Dr : Hala El-sayed Mahmoud
Histology Techniques CLS 322
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Surgical Oncology Surgical Oncology 04/21/12 – 04/27/2012 David Williams Andy Young Justin Brown Xi Bei Tian Jonathan Young.
The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.
Radiotherapy Protocols Bristol protocol version 12.
TISSUE PREPARATION.
Pathology.
Basis and Outcome of Axillary Dissection for Node Negative Axilla Gurpreet Singh Dept. Of Surgery P.G.I.M.E.R. These Power Point presentations are free.
W. Scott Campbell, Ph.D., MBA University of Nebraska Medical Center
George Cernile, Manager A.I. Technology Group Artificial Intelligence In Medicine Inc. Advancements in Automated Synoptic Reporting.
Jacob J. Adler.  The following slides are meant for students to navigate on their own or in small groups.  They are expected to have time to research.
PATHOLOGY OF NECK DISSECTION. VIEW FROM DEEP ASPECT OF NECK DISSECTION.
Measuring Coding Accuracy Artificial Intelligence in Medicine National Cancer Institute.
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Copyright © 2013 American Medical Association. All rights reserved.
Appropriate Sampling of Lumpectomy Specimens
Prostate Cancer Dr .Gehan Mohamed.
بسم الله الرحمن الرحيم Department of Pathology College of Medicine
Sonography of the Breast Part III Lecture 12 Invasive Procedures
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
بسم الله الرحمن الرحيم Department of Pathology College of Medicine
W. Scott Campbell, MBA, PhD University of Nebraska Medical Center
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Treatment Overview: The Multidisciplinary Team
Tissue processing Histology:
Presentation transcript:

Surgical Pathology of Wide Local Excision of Breast Venkateswaran K Iyer Assistant Professor Department of Pathology ALL INDIA INSTITUTE OF MEDICAL SCIENCES These Power Point presentations are free to download only for academic purposes, with due acknowledgements to authors and this website.

The Specimen Oval of overlying skin, including any scar Suture tags : 3 (2 with skin) Superior margin with one silk suture Lateral margin with two silk sutures The specimen should not be cut by the surgeon This interferes with gross identification and inking of margins

Key Issues in Grossing Exact tumor size Ductal Carcinoma in Situ Surgical margins

Tumor Size Measurement Gross size of tumor measured with a scale Two cross sections with maximum diameter Process cross section of entire tumor Within one slide if < 1 cm Measure size of tumor on microscope stage Stage vernier Compare gross and microscopic size Tumor shows 10-20% shrinkage on slide

Gross size measurement Microscopic examination is used to revise the basic gross measurement downwards

Gross size measurement Microscopic examination is used to revise the basic gross measurement upwards

When is this Important? When tumor size is 0.5 – 2 cm on gross TNM: T 1 is < 2 cm T 1a : < 0.5 cm Van Nuys (DCIS) T 1b : 0.5 – 1.0 cm 1.5 cm T 1c : 1.0 – 2.0 cm Tumor size < 1cm have 10-15% nodal metastasis and 90% ten year survival

DCIS Present alone (mammographic detection) Present adjacent to a carcinoma Size measurement is important Evaluation of margins is very important Only DCIS: Prognostic relevance Adjacent to Ca: Complicates the proper evaluation of margins

Van Nuys Prognostic Index Van Nuys Score Feature 1 2 3 Tumor size (mm) <15 16-40 >40 Margin (mm) >10 1-9 <1 Pathology grade 1 2 3 Necrosis - + +/- Nuclear Grade 1-2 1-2 3

Evaluation of Margins Tumor bed biopsy by surgeon Specimen scrape cytology Shaved margins: sampling by pathologist Shaved margins: total Inked margins

Evaluation of Margins Tumor bed biopsy by surgeon Specimen scrape cytology Shaved margins: sampling by pathologist Shaved margins: total Inked margins

Evaluation of Margins Tumor bed biopsy by surgeon Specimen scrape cytology Shaved margins: sampling by pathologist Shaved margins: total Inked margins

Inking the Margins Paint entire surface of specimen with ink Nature of ink: Insoluble Water, formalin Alcohol Acetone Xylene Paraffin Cut into the specimen margin for sections. Ink on margin will be visible on microscopy

Inking Alternatives India Ink Mercurochrome Alcian Blue with Picric Acid fixation Method: Fix uncut specimen for 30 mins in formalin, blot Paint the surface of specimen with the ink Wait for 15 mins to dry Keep in formalin for another 15 mins to wash away excess ink and to fix the ink Serial section the specimen and overnight fix

Ideal: Sequential Processing The entire specimen is processed Sequential serial sections end to end

Infiltrating duct carcinoma at inked margin Ink washout: tumor close to margin DCIS 5 mm from margin

Surrounding Breast DCIS or LCIS Atypical ductal/lobular hyperplasia Lymphatic permeation Pagetoid spread along the ducts

Future Options Muc1 RT-PCR of drainage fluid Specimen scrape cytology Sentinel Lymph Node imprint cytology

Summary: Must Do’s of Pathology Accurate tumor size measurement Assessment of margins in wide local excision Tumor bed sampling by surgeon Shave sampling by pathologist Inking of small excision samples Proper evaluation of DCIS component and its relation to margin

What is an adequate margin >=1 cm: Adequate >=5 mm: Not adequate, evaluate 1 -5 mm: Inadequate <=1mm: Positive margin

Thank You